Harpoon Therapeutics Inc (HARP) concluded trading on Thursady at a closing price of $22.96, with 5.65 million shares of worth about $129.74 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 184.90% during that period and on Thursady the price saw a gain of about 1.50%. Currently the company’s common shares owned by public are about 16.95M shares, out of which, 9.90M shares are available for trading.
However, the stock later moved at a day high price of 22.96, or with a gain of 1.50%. Stock saw a price change of 2.27% in past 5 days and over the past one month there was a price change of 2.50%. Year-to-date (YTD), HARP shares are showing a performance of 101.93% which increased to 175.80% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.11 but also hit the highest price of $22.88 during that period. The average intraday trading volume for Harpoon Therapeutics Inc shares is 874.60K. The stock is currently trading 2.48% above its 20-day simple moving average (SMA20), while that difference is up 28.16% for SMA50 and it goes to 131.55% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Harpoon Therapeutics Inc (NASDAQ: HARP) currently have 16.95M outstanding shares and institutions hold larger chunk of about 75.96% of that.
The stock has a current market capitalization of $389.17M and its 3Y-monthly beta is at 2.11. It has posted earnings per share of -$8.71 in the same period. It has Quick Ratio of 1.89 while making debt-to-equity ratio of 3.19. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HARP, volatility over the week remained 0.88% while standing at 0.73% over the month.
Analysts are in expectations that Harpoon Therapeutics Inc (HARP) stock would likely to be making an EPS of -$0.64 in the current quarter, while forecast for next quarter EPS is -$0.82 and it is -$3.66 for next year. For the current quarter EPS, analysts have given the company a lowest target -$1.14 which is -$0.03 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$5.5 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 89.77% while it is estimated to decrease by -63.74% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Oppenheimer on January 05, 2024 offering an Outperform rating for the stock and assigned a target price of $23 to it. On July 06, 2022, Canaccord Genuity Resumed their recommendations, while on September 28, 2021, Citigroup Upgrade their ratings for the stock with a price target of $16. Stock get a Neutral rating from Citigroup on June 08, 2021.
